Combination of serum paraoxonase/arylesterase 1 and antithrombin-III is a promising non-invasion biomarker for discrimination of AFP-negative HCC versus liver cirrhosis patients
2021 ◽
Vol 45
(5)
◽
pp. 101583
◽
2014 ◽
Vol 219
(5)
◽
pp. 865-874
◽
2012 ◽
Vol 44
(9)
◽
pp. 765-773
◽
1988 ◽
Vol 52
(4)
◽
pp. 325-336
◽
2009 ◽
Vol 104
◽
pp. S158-S159
Keyword(s):
1996 ◽
Vol 57
(4)
◽
pp. 804-809
Keyword(s):
Keyword(s):
Keyword(s):